Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Stang

Showing results (391-400 of 442) with videos related to

Pageof 45
Sort By:
Scientific Data|December 5, 2023
Chronic disease outcome metadata from German observational studies - public availability and FAIR principlesCarolina Schwedhelm, Katharina Nimptsch, Wolfgang Ahrens, et al.
European Journal of Radiology|May 7, 2020
Impact of <sup>18</sup>F-FDG PET/MR on therapeutic management in high risk primary breast cancer patients - A prospective evaluation of staging algorithmsJulian Kirchner, Ole Martin, Lale Umutlu, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2025
Clinical course of Merkel cell carcinoma: A DeCOG multicenter study of 1049 patientsGeorg C Lodde, Ulrike Leiter, Anja Gesierich, et al.
BMJ Open Sport & Exercise Medicine|October 7, 2024
SoccHealth: a health status examination of former professional football (soccer) players within the German National CohortKlaus Berger, Hansjoerg Baurecht, Michael Stein, et al.
Deutsches Arzteblatt International|August 19, 2024
Baseline MRI Examination in the NAKO Health Study—Findings on Feasibility, Participation and Dropout Rates, Comfort, and Image QualityFabian Bamberg, Christopher L Schlett, Svenja Caspers, et al.
European Journal of Epidemiology|June 2, 2022
Statistical Analysis in the German National Cohort (NAKO) - Specific Aspects and General RecommendationsOliver Kuss, Heiko Becher, Andreas Wienke, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2024
Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockadeEleftheria Chorti, Bernd Kowall, Jessica C Hassel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2024
Impact of <sup>18</sup>F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center TrialKai Jannusch, Lale Umutlu, Julian Kirchner, et al.
The Lancet. Oncology|August 1, 2024
Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective studyMadeleine J Karpinski, Johannes Hüsing, Kevin Claassen, et al.
JCO Precision Oncology|September 11, 2020
Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically Heterogeneous Metastatic MelanomaRenáta Váraljai, Kilian Wistuba-Hamprecht, Teofila Seremet, et al.
Pageof 45

Showing results (391-400 of 442) with videos related to

Sort By:
Pageof 45
Scientific Data|December 5, 2023
Chronic disease outcome metadata from German observational studies - public availability and FAIR principlesCarolina Schwedhelm, Katharina Nimptsch, Wolfgang Ahrens, et al.
European Journal of Radiology|May 7, 2020
Impact of <sup>18</sup>F-FDG PET/MR on therapeutic management in high risk primary breast cancer patients - A prospective evaluation of staging algorithmsJulian Kirchner, Ole Martin, Lale Umutlu, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2025
Clinical course of Merkel cell carcinoma: A DeCOG multicenter study of 1049 patientsGeorg C Lodde, Ulrike Leiter, Anja Gesierich, et al.
BMJ Open Sport & Exercise Medicine|October 7, 2024
SoccHealth: a health status examination of former professional football (soccer) players within the German National CohortKlaus Berger, Hansjoerg Baurecht, Michael Stein, et al.
Deutsches Arzteblatt International|August 19, 2024
Baseline MRI Examination in the NAKO Health Study—Findings on Feasibility, Participation and Dropout Rates, Comfort, and Image QualityFabian Bamberg, Christopher L Schlett, Svenja Caspers, et al.
European Journal of Epidemiology|June 2, 2022
Statistical Analysis in the German National Cohort (NAKO) - Specific Aspects and General RecommendationsOliver Kuss, Heiko Becher, Andreas Wienke, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2024
Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockadeEleftheria Chorti, Bernd Kowall, Jessica C Hassel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2024
Impact of <sup>18</sup>F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center TrialKai Jannusch, Lale Umutlu, Julian Kirchner, et al.
The Lancet. Oncology|August 1, 2024
Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective studyMadeleine J Karpinski, Johannes Hüsing, Kevin Claassen, et al.
JCO Precision Oncology|September 11, 2020
Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically Heterogeneous Metastatic MelanomaRenáta Váraljai, Kilian Wistuba-Hamprecht, Teofila Seremet, et al.
Pageof 45